US4886493A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Medical applicator process
Assignee: Individual
•
Filing: 1987-10-22
•
Granted: 1989-12-12
•
Expires: 2007-10-22
Abstract
Abstract An applicator and process for accomplishing the Sphenopalatine Ganglion Block wherein an extended tube of a fixed length and width is used. The amount of medication administered is critical and should be between about 1/16 c.c. and about 3/8 c.c.; an amount below this range will be substantially ineffective, and above this range could have serious side effects. The applicator tube is flexible and must have depth indicators for proper usage.
Inventors
- 👤 Jordan Yee
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:45
CPC Classifications
A; A61; A61M; A61M11/00; A61M15/00; A61M15/08; A61M15/085; A61M31/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
123 words
A process for accomplishing the Sphenopalatine Ganglion Block in a patient which comprises inserting a flexible tube in an air tight manner to a containing vessel having a measured amount of lidocaine therein and capable of delivering a jet stream spray of its contents, said lidocaine having a concentration of from about 1% to about 20%, inserting said tube into said patient's nose until the frontal terminal portion of said tube reaches the pterygopalatine fossa area, delivering an amount from about 1/16 c.c. to about 3/8 c.c. of said lidocaine from said containing vessel to said ptyergopalatine fossa area via said tube, maintaining said tube in said patient's nose until said amount of lidocaine is completely delivered in spray form to said area.
Claim 2
Dependent Claim
123 words
A process for accomplishing the Sphenopalatine Ganglion Block in a patient which comprises inserting a flexible tube in an air tight manner to a containing vessel having a measured amount of lidocaine therein and capable of delivering a jet stream spray of its contents, said lidocaine having a concentration of from about 1% to about 20%, inserting said tube into said patient's nose until the frontal terminal portion of said tube reaches the pterygopalatine fossa area, delivering an amount from about 1/16 c.c. to about 3/8 c.c. of said lidocaine from said containing vessel to said ptyergopalatine fossa area via said tube, maintaining said tube in said patient's nose until said amount of lidocaine is completely delivered in spray form to said area.
Claim 3
Dependent Claim
15 words
The process of claim 1 wherein said containing vessel is attached to said flexible tube.
Claim 4
Dependent Claim
15 words
The process of claim 1 wherein said containing vessel is co-extensive with said flexible tube.
Claim 5
Dependent Claim
26 words
The process of claim 1 wherein about 0.1 c.c. of lidocaine per activation is administered in said area with the employment of at least one activation.
Claim 6
Dependent Claim
16 words
The process of claim 1 wherein about 1/16 c.c. of lidocaine is sprayed in said area.
Claim 7
Dependent Claim
16 words
The process of claim 1 wherein about 3/8 c.c. of lidocaine is sprayed in said area.
Claim 8
Dependent Claim
12 words
The process of claim 1 wherein said lidocaine is in liquid form.
Claim 9
Dependent Claim
120 words
A process for accomplishing the Sphenopalatine Ganglion Block in a patient which comprises, providing a flexible tube in an air tight manner to a containing vessel having a measured amount of lidocaine therein and capable of delivering lidocaine as a gel, said lidocaine having a concentration of from about 1% to about 2%, inserting said tube into said patient's nose until the frontal terminal portion of said tube reaches the pterygopalatine fossa area, delivering an amount from about 1/16 c.c. to about 3/8 c.c. of said lidocaine from said containing vessel to said ptyergopalatine fossa area via said tube, maintaining said tube in said patient's nose until said amount of lidocaine is completely delivered in gel form to said area.
Claim 10
Dependent Claim
120 words
A process for accomplishing the Sphenopalatine Ganglion Block in a patient which comprises, providing a flexible tube in an air tight manner to a containing vessel having a measured amount of lidocaine therein and capable of delivering lidocaine as a gel, said lidocaine having a concentration of from about 1% to about 2%, inserting said tube into said patient's nose until the frontal terminal portion of said tube reaches the pterygopalatine fossa area, delivering an amount from about 1/16 c.c. to about 3/8 c.c. of said lidocaine from said containing vessel to said ptyergopalatine fossa area via said tube, maintaining said tube in said patient's nose until said amount of lidocaine is completely delivered in gel form to said area.
References Cited (Backward Citations)
US598286A
Cited
US645566A
Cited
US2470297A
Cited
US2672141A
Cited
US3747595A
Cited
US4300557A
Cited
US4402684A
Cited
US4479800A
Cited
US4737141A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-12-11 | 1993-06-12 | 1993-12-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-12-11 | 1997-06-12 | 1997-12-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-12-11 | 2001-06-12 | 2001-12-12 | $7700.00 | Window Closed / Lapsed |